Magnetic Stimulation to Treat VT Storm
Magnetic Stimulation to Treat VT Storm
Ventricular Tachycardia storm is a medical emergency characterized by three or more episodes
 of ventricular arrhythmia within 24 hours and associated with a significantly increased
 mortality and massive health resource utilization. Several therapies are utilized including
 sympathetic blockade (through deep sedation and beta blockers), antiarrhythmic drugs,
 implantable cardioverter defibrillator (ICD) reprograming where applicable, and catheter
 ablation. Despite standard intervention, mortality rates remain high and additional
 therapeutic options are actively being investigated.

 The overall objective of this proposal is to investigate whether transcutaneous magnetic
 stimulation designed to inhibit the left stellate ganglion can be used in this population.
 This is a single-center, randomized, sham-controlled trial to assess the efficacy of
 transcutaneous magnetic stimulation of the left stellate ganglion to treat patients with
 ventricular tachycardia storm.
Inclusion Criteria:

 -  ≥ 3 episodes of VT in 24 hours

 Exclusion Criteria:

 -  Pregnancy

 -  Implanted ventricular assist device

 -  Metal implanted in head or neck (except the mouth)

 -  Implanted medication pumps

 -  Cochlear implant

 -  Implanted brain stimulator

 -  Ocular implant

 -  History of malignancy in region of stimulation (neck)